TABLE 2

Subjects without COPD (noCOPD) according to maximum mid-expiratory flow (MMEF) above and below 80%

NoCOPD MMEF <80%NoCOPD MMEF >80%p-value
Subjects n13574
Age years54.05±11.0547.82±9.310.01
BMI kg·m−228.75±4.9927.18±4.950.01
Smoking history pack-years45.17±25.5738.10±20.920.048
Active smokers, n (%)61 (45)33 (45)ns
CAT score9.42±6.848.24±6.94ns
Subjects with CAT ≥10, n (%)47 (35)23 (31)ns
Distance at 6MWT m459±109519±1140.01
Number of total exacerbations per year0.56±1.120.36±0.910.04
Subjects with CB n (%)42 (31)14 (19)0.04
Subjects with mMRC ≥2, n (%)49 (36)22 (30)ns
mMRC score1.23±1.190.85±1.150.01
Subjects with DLCO <80%56 (41)24 (32)ns
DLCO % pred84± 1889±17ns
FEV1 % pred90.74±12.74105.11±12.740.0001
FEV1/FVC %76.39±3.982.31±3.890.0001
Subjects who develop COPD at V3, n (%)28(21)2(2.7)0.001

Data are presented as n (%), and mean±sd. p-value refers to Mann–Whitney test or χ2 test. ns: nonsignificant; BMI: body mass index; CAT: COPD Assessment Test; 6MWT: 6-min walk test; CB: chronic bronchitis; mMRC: modified Medical Research Council; DLCO: diffusing capacity of the lung for carbon monoxide; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; V3: third visit..